New Key Statistics Module, Z-Score and F-Score
NAS:HALO Key Ratios
Market Cap $ M | 4,844.58 |
Enterprise Value $ M | 5,970.98 |
P/E(ttm) | 18.07 |
PE Ratio without NRI | 17.49 |
Forward PE Ratio | 12.46 |
Price/Book | 57.77 |
Price/Sales | 6.17 |
Price/Free Cash Flow | 13.66 |
Price/Owner Earnings | 13.99 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 829.00 |
EPS (TTM) $ | 2.11 |
Beneish M-Score | -2.82 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 50.10 |
EV-to-EBIT | 16.27 |
EV-to-EBITDA | 13.21 |
PEG | -- |
Shares Outstanding M | 127.05 |
Net Margin (%) | 33.96 |
Operating Margin % | 40.71 |
Pre-tax Margin (%) | 42.01 |
Quick Ratio | 5.50 |
Current Ratio | 6.64 |
ROA % (ttm) | 15.68 |
ROE % (ttm) | 195.64 |
ROIC % (ttm) | 20.60 |
Dividend Yield % | -- |
Altman Z-Score | 3.44 |
Piotroski F-Score | 6.00 |
Positive ROA | Y |
Positive CFROA | Y |
Higher ROA y-y | N |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
HALO Number of Guru Trades
HALO Volume of Guru Trades
Gurus Latest Trades with NAS:HALO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HALO is held by these investors
Total 3
Halozyme Therapeutics Inc Insider Transactions
No Available Data
News about NAS:HALO
Total 0- 1